Seaport Global Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,834
Closed -$258K 60
2023
Q4
$258K Hold
4,834
0.62% 53
2023
Q3
$240K Sell
4,834
-569
-11% -$31.8K 0.72% 50
2023
Q2
$322K Buy
5,403
+1,757
+48% +$100K 0.95% 35
2023
Q1
$207K Sell
3,646
-4,001
-52% -$257K 0.65% 64
2022
Q4
$568K Buy
7,647
+1,673
+28% +$114K 1.97% 5
2022
Q3
$356K Buy
5,974
+1,027
+21% +$61.8K 1.45% 11
2022
Q2
$278K Buy
+4,947
New +$325K 1.04% 31

Other funds holding GMED

Seaport Global Advisors's GMED Position: Q1 2024 in Review

Seaport Global Advisors sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 4,834 shares — an estimated $258K sold.

Seaport Global Advisors first reported a position in GMED in Q2 2022 and held it in 7 quarters. The position peaked at $568K in Q4 2022. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Seaport Global Advisors reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Seaport Global Advisors sold 4,834 Globus Medical shares in Q1 2024, an estimated $258K.
  • Seaport Global Advisors first reported a position in Globus Medical in Q2 2022 and held it in 7 quarters.
  • Seaport Global Advisors's Globus Medical position peaked at $568K in Q4 2022.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Seaport Global Advisors's 13F filing for Q1 2024, filed 15 May 2024.